Attached files

file filename
8-K/A - ADVANCED PHOTONIX, INC. 8-K/A - ADVANCED PHOTONIX INCa50168174.htm
Exhibit 99.1


     ADVANCED PHOTONIX, INC. REPORTS
THIRD QUARTER 2012 RESULTS

Ann Arbor, MI, February 13, 2011 --Advanced Photonix, Inc.® (NYSE Amex API) (the “Company”) today reported its third quarter fiscal 2012 results ending December 30, 2011.

Financial Highlights for the Third Quarter compared to the prior year

  
The Company's revenues for the quarter ended December 30, 2011 were $6.5 million, a decrease of 16% (or $1.2 million) from revenues of $7.7 million for the quarter ended December 31, 2010.
 
  
Gross Profit for Q3 2012 was $2.7 million compared to Q3 2011 of $3.1 million, or a decrease of 13%.
 
  
Operating expenses were $3.6 million for the quarter as compared to $3.3 million for the comparable prior year period, an increase of $296,000.
 
  
Quarterly net loss was $812,000 or $0.03 per diluted share, as compared to a net loss of $649,000, or $0.03 per diluted share, for the quarter ended December 31, 2010.
 
  
The Non-GAAP net loss for the third quarter of fiscal 2012 was $317,000 or $0.01 per diluted share, as compared to a Non-GAAP net profit of $259,000 or $0.01 per diluted share, for the comparable prior year period. Non-GAAP income and loss information eliminates certain non-cash adjustments required under generally accepted accounting principles in the United States.
 
  
EBITDA (which is defined as GAAP earnings before interest, taxes, depreciation, and amortization), was a  negative $236,000 for the third quarter of fiscal 2012 as compared to positive EBITDA of $472,000 for the comparable prior year period.
 
Financial Highlights for the Nine Months ended December 30, 2011 compared to the Nine months ended December 31, 2010

  
Net Sales for the nine months were $23 million, an increase of $2 million or 10% compared to the nine months ended December 31, 2010.
 
  
Year to date gross profit margin increased $731,000 or 8% over the prior year nine months ended December 31, 2010.
 
  
Operating expenses were $11.3 million for the nine months ended December 30, 2011 as compared to $9.5 million for the comparable prior year.
 
  
Net loss for the nine months ended December 30, 2011 was $1.0 million or $0.03 per diluted share, as compared to a net loss of $1.3 million, or $0.05 per diluted share for the comparable prior year.
 
  
The Non-GAAP net loss for the first nine months of fiscal 2012 was $259,000 or $0.01 per diluted share, as compared to a Non-GAAP net income of $565,000 or $0.02 per diluted share for the comparable prior year.
 
  
EBITDA (which is defined as GAAP earnings before interest, taxes, depreciation, and amortization), was a positive $193,000 for the first nine months of fiscal 2012 as compared to an EBITDA of a positive $1.3 million for the comparable prior year.
 
 
 

 
 
Market Highlights for the Nine Months ended December 30, 2011, compared to the Nine Months ended December 31, 2010
  
Telecommunication revenue up 33% or $2.3 million
  
Medical Market revenue up 23% or $152,000
  
Homeland security market revenues up $921,000
  
Military revenue down 16% or $633,000
  
Industrial/NDT revenue down 8% or $758,000

Richard Kurtz, Chairman and Chief Executive Officer, commented, "Our third quarter results were as expected, down in light of the flooding in Thailand which affected the supply chain for our major telecommunications customers, as well as the timing of orders in the military market. While the first half of the year was strong in the telecommunications market, as we stated last quarter revenues in the second half are expected to be down substantially.  We believe that this is primarily attributable to the temporary supply chain issue and not a lack of long term demand for our 40G and 100G products. We expect a return to the robust growth we enjoyed in the first half of this fiscal year to return in our next fiscal year. We are continuing to sell our T-Ray systems into industrial applications and are working closely with our customers to establish a Value Added Reseller channel to install, integrate and service our systems. With our new banking relationship we have the financial strength to continue investing in our high growth opportunities and are optimistic about our long term future, but as we stated last quarter, for this fiscal year we are reducing our annual revenue growth for this fiscal year to a maximum of 5% year over year.”

The Company will hold a conference call to discuss the results for the second quarter Monday, February 13, 2012, at 4:30 PM EST.

The conference call will be webcast live and will be accessible at http://investor.advancedphotonix.com. Participants can dial into the conference call at 888.679.8033 (617.213.4846 for international) using the passcode 89252680.

 
An audio replay of the call will be available shortly thereafter on the same day and will remain on-line until February 20, 2012. The replay number is 888.286.8010 (617.801.6888 for international) and the passcode is 89328044.
 

Forward-looking Statements:
The information contained herein includes forward looking statements that are based on assumptions that management believes to be reasonable but are subject to inherent uncertainties and risks including, but not limited to, unforeseen technological obstacles which may prevent or slow the development and/or manufacture of new products; potential problems with the integration of the acquired company and its technology and possible inability to achieve expected synergies; obstacles to successfully combining product offerings and lack of customer acceptance of such offerings; limited (or slower than anticipated) customer acceptance of new products which have been and are being developed by the Company; and a decline in the general demand for optoelectronic products. API-G

 
 

 

Condensed Consolidated Balance Sheets
             
Assets
 
December 30, 2011
 
March 31, 2011
   
(unaudited)
     
Current Assets
           
Cash and cash equivalents
  $ 3,621,000     $ 4,744,000  
Restricted cash
    -       500,000  
Accounts receivable, net of allowance
    3,922,000       4,587,000  
Inventories, net of  allowances
    4,324,000       4,775,000  
Prepaid expenses and other current assets
    402,000       349,000  
Total current assets
    12,269,000       14,955,000  
Equipment & Leasehold Improvements, at cost
    12,987,000       12,505,000  
Accumulated depreciation
    (9,520,000 )     (8,775,000 )
Net Equipment and Leasehold Improvements
    3,467,000       3,730,000  
Goodwill, net of accumulated amortization
    4,579,000       4,579,000  
Patents, net
    1,172,000       1,062,000  
Intangible assets, net
    3,672,000       4,651,000  
Other assets
    266,000       275,000  
Total assets
  $ 25,425,000     $ 29,252,000  
                 
Liabilities and shareholders' equity
               
Current liabilities
               
Accounts payable and accrued expenses
  $ 1,708,000     $ 3,031,000  
Compensation and related withholdings
    808,000       953,000  
Accrued warrant liability
    -       389,000  
Current portion of long-term debt-related parties
    726,000       675,000  
Current portion of long-term debt-bank term loan
    958,000       687,000  
    Current portion of bank line of credit
    -       494,000  
Current portion of long-term debt-MEDC/MSF
    482,000       511,000  
Total current liabilities
    4,682,000       6,740,000  
Long term debt, less current portion-MEDC/MSF
    1,064,000       1,460,000  
Long term debt, less current portion - related parties
    -       500,000  
Long term debt portion - warrant liability
    13,000       343,000  
Total liabilities
    5,759,000       9,043,000  
                 
Shareholders' equity
               
Class A common stock, $.001 par value, 100,000,000 shares authorized;
December  30, 2011 - 30,968,716 shares issued and outstanding;
March 31, 2011 - 30,679,046 shares issued and outstanding
    31,000       31,000  
Additional paid-in capital
    58,396,000       57,891,000  
Accumulated deficit
    (38,761,000 )     (37,713,000 )
Total shareholders' equity
    19,666,000       20,209,000  
                 
Total liabilities and shareholders' equity
  $ 25,425,000     $ 29,252,000  
 
 
 

 
 
Consolidated Statement of Operations (unaudited)
 
   
Three months ended
 
Nine months ended
   
December 30, 2011
 
December 31, 2010
 
December 30, 2011
 
December 31, 2010
Net Sales
  $ 6,518,000     $ 7 ,720,000     $ 22,991,000     $ 20,972,000  
Cost of Sales
    3,828,000       4,636,000       13,356,000       12,068,000  
Gross Margin
    2,690,000       3,084,000       9,635,000       8,904,000  
                                 
Other Operating Expenses
                               
   Research & Development
    1,660,000       1,362,000       5,066,000       3,953,000  
   General & Administrative
    1,062,000       1,028,000       3,521,000       2,992,000  
   Amortization
    344,000       409,000       1,028,000       1,223,000  
   Sales & Marketing
    484,000       455,000       1,664,000       1,352,000  
Total Other Operating Expenses
    3,550,000       3,254,000       11,279,000       9,520,000  
                                 
Net Operating Loss
    (860,000 )     (170,000 )     (1,644,000 )     (616,000 )
                                 
Other (Income) & Expense
                               
  Other (Income)/Expense
    (3,000 )     (1,000 )     (3,000 )     1,000  
  Change in fair value of warrant liability
    (84,000 )     97,000       (719,000 )     186,000  
  Loss on debt extinguishment
    -       318,000       -       318,000  
  Interest Income
    (1,000 )     -       (5,000 )     (2,000 )
  Interest Expense-Related Parties
    10,000       15,000       38,000       45,000  
  Interest Expense
    30,000       50,000       93,000       156,000  
Other (Income) & Expense
    (48,000 )     479,000       (596,000 )     704,000  
                                 
Net Loss
  $ (812,000 )   $ (649,000 )   $ (1,048,000 )   $ (1,320,000 )
Basic & diluted earnings per share
  $ (0.03 )   $ (0.03 )   $ (0.03 )   $ (0.05 )
                                 
Weighted number of shares outstanding - Basic & diluted
    30,972,000       25,908,000       30,828,000       25,410,000  
 
Non-GAAP Financial Measures
 
The Company provides Non-GAAP Net Income and EBITDA as supplemental financial information regarding the Company's operational performance. These Non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles in the United States. Non-GAAP Net Income and EBITDA should not be considered in isolation from or as a substitute for financial information presented in accordance with generally accepted accounting principles, and may be different from similar measures used by other companies. Reconciliation of Non-GAAP Net Income and EBITDA to GAAP net income and loss are set forth in the financial schedule section below.
 
 
 

 
 
Reconciliation of Non-GAAP Income (loss) to GAAP Income (loss)
 
   
Three months ended
 
Nine months ended
   
December 30, 2011
 
December 31, 2010
 
December 30, 2011
 
December 31, 2010
Net Loss
  $ (812,000 )   $ (649,000 )   $ (1,048,000 )   $ (1,320,000 )
Add Back:
                               
  Change in warrant fair value
    (84,000 )     97,000       (719,000 )     186,000  
  Loss on debt extinguishment
    -       318,000       -       318,000  
  Amortization - intangibles/patents
    344,000       409,000       1,028,000       1,223,000  
  Stock Option Compensation Expense
    235,000       84,000       480,000       158,000  
     Subtotal - Add backs
    495,000       908,000       789,000       1,885,000  
Non-GAAP Income(loss)
  $ (317,000 )   $ 259,000     $ (259,000 )   $ 565,000  
                                 
Net earnings per share
  $ (0.01 )   $ 0.01     $ (0.01 )   $ 0.02  
                                 
Weighted number of shares outstanding - Basic & diluted
    30,972,000       25,908,000       30,828,000       25,410,000  


Reconciliation of EBITDA to GAAP income/(loss)
 
   
Three months ended
 
Nine months ended
   
December 30, 2011
 
December 31, 2010
 
December 30, 2011
 
December 31, 2010
Net Loss
  $ (812,000 )   $ (649,000 )   $ (1,048,000 )   $ (1,320,000 )
Add Back:
                               
  Net Interest expense
    39,000       65,000       126,000       199,000  
  Change in warrant fair value
    (84,000 )     97,000       (719,000 )     186,000  
  Loss on debt extinguishment
    -       318,000       -       318,000  
  Depreciation expense
    277,000       232,000       806,000       707,000  
  Amortization
    344,000       409,000       1,028,000       1,223,000  
     Subtotal - Add backs
    576,000       1,121,000       1,241,000       2,633,000  
EBITDA
  $ (236,000 )   $ 472,000     $ 193,000     $ 1,313,000  

About Advanced Photonix, Inc.
Advanced Photonix, Inc.® (NYSE Amex: API) is a leading supplier with a broad offering of optoelectronic products to a global customer base. We provide optoelectronic solutions, high-speed optical receivers and terahertz instrumentation for telecom, homeland security, military, medical and industrial markets. With our patented technology and state-of-the-art manufacturing we offer industry leading performance, exceptional quality, and high value-added products to our OEM customer base. For more information visit us on the web at www.advancedphotonix.com.